BioSpace News Archive

Kapoose Creek Bio, a Vancouver-based biotechnology company leveraging AI for drug discovery from nature, announced the identification and advancement of two lead compounds with exciting potential in neurology, spanning indications in neurodegeneration and mental health.

RenovoRx, Inc., a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, provided a letter to shareholders from Chief Executive Officer, Shaun Bagai.

Silence Therapeutics plc today announced the Company will present at the Jefferies Global Healthcare Conference on Thursday, June 6th at 2:30 p.m. ET.

Faeth Therapeutics announced today that Anand Parikh, Chief Executive Officer (CEO), will participate in one-on-one investor meetings at the upcoming Jefferies Global Healthcare Conference being held June 4-6 in New York.

Sermonix Pharmaceuticals Inc. today announced it will present a poster updating the progress of its Phase 3 ELAINE-3 clinical trial at the annual meeting of the American Society of Clinical Oncology (ASCO). ASCO 2024 will be held May 31-June 4, 2024, at McCormick Place in Chicago.

AVITA Medical, Inc. announced that the U.S. Food and Drug Administration has approved its premarket approval supplement for the RECELL GO™ System, its next-generation autologous cell harvesting device that harnesses the regenerative properties of a patient’s own skin to treat thermal burn wounds and full-thickness skin defects.

Sarah Cannon Research Institute announced that it will highlight its latest research insights through more than 145 presentations at the 2024 American Society of Clinical Oncology Annual Meeting from Friday, May 31 – Tuesday, June 4 in Chicago, Ill.

Sanofi, a global healthcare company, announced the opening of a new state-of-the-art pediatric and adult vaccine manufacturing facility at its Toronto Campus.

Medable Inc. today announced that Medable Co-founder and CEO Michelle Longmire will present at the Jefferies Global Healthcare Conference.